Stapled cell-penetrating peptides conjugate to oligonucleotides via bi-functional linkers, reducing toxicity while maintaining cellular uptake.
D-beta-hydroxybutyrate ester reduces muscle glycogen loss and protein breakdown during intense exercise.
Agents stabilize fibrosis by inhibiting matrix remodeling while promoting physiological wound healing.
Antibodies bind pro/latent Myostatin to block activation, avoiding side effects from broader TGFβ pathway inhibition.
A composite extract of Angelica keiskei and mulberry leaves promotes muscle building by suppressing protein breakdown.
A peripheral nerve-mimicking microtissue enhances neuroregenerative effects by increasing the expression and secretion of neurotrophic factors.
Replacing cysteines with serines in HMGB1 prevents oxidative inactivation and cytokine stimulation while maintaining chemoattractant activity for tissue repair.
A laminin E8 fragment conjugated to a perlecan domain 1 growth factor binding region supports pluripotent stem cell culture.
A herbal composition activates phagocytic macrophages to clear senescent cells in skeletal muscle.
Targeted splicing modulation increases SMN protein levels without the long-term safety risks associated with non-specific histone deacetylase inhibitors.
Antibody-oligonucleotide complexes bind transferrin receptors on muscle cells to enable targeted intracellular delivery of therapeutic payloads.
Culture medium composition directs musculoskeletal stem cell differentiation into bone and cartilage tissues.
Anti-C5 antibody eculizumab blocks complement cascade activation to reduce neuromuscular junction injury, eliminating the need for repeated plasma exchange.
Targeting LSD1 demethylase activity increases muscle mass and strength while preventing atrophy in sarcopenia.
Urolithin composition increases urinary creatinine and enhances albumin reabsorption.
Covalently linking oligonucleotides to trimeric peptides resolves the contradiction between antisense reliability and cellular uptake efficiency.
Administering EHMT2 inhibitors with additional agents modulates T cell activity to treat immune-mediated diseases.
An NK1 antagonist blocks neurokinin-1 receptors to mitigate gastrointestinal adverse effects, allowing maximally effective neostigmine dosing.
Carbamate compounds suppress muscle cell excitability to treat myotonia, overcoming side effects and limited efficacy of existing therapies like mexiletine.
Allosteric proteasome modulators reduce muscle degradation and promote protein synthesis, addressing toxicity limits of existing agonists.
Hydroxypropyl methylcellulose in the extragranular portion controls dissolution, achieving at least 80% mean drug release between 6 and 10 hours.
Schizonepeta tenuifolia extract improves muscle endurance and fiber organization while reducing kidney burden from high protein intake.
Vaccine combining antigen and IL-23 adjuvant resolves inconsistency across tissues by stabilizing Th17 cells for uniform response.
Isoform-specific TGFβ1 antibodies bind GARP complexes to inhibit signaling, avoiding pan-TGFβ toxicities.
EDTA or heparin treatment separates Lgr5+ somatic stem cells from bone marrow tissue samples into distinct layers for precise isolation.
Stitched reinforcing fibers in the ECM patch increase suture retention strength and failure load, preventing tendon tearing during healing.
Measuring anti-vinculin antibody levels resolves diagnostic precision issues in systemic sclerosis gastrointestinal involvement.
Segmented bottlebrush polymers improve membrane stabilization by combining hydrophobic and hydrophilic blocks to overcome limited poloxamer efficacy.
Small molecules expand the endogenous satellite cell pool to repair damaged muscle tissue without compromising myogenic differentiation potential.
A leucine and antioxidant nutritional composition accelerates post-prandial muscle protein synthesis to restore tissue mass.
A biocompatible matrix seeded with substantially pure mesenchymal stem cells promotes soft tissue repair.
Conjugates incorporating non-canonical amino acids improve antisense oligomer delivery by enhancing cellular uptake while maintaining therapeutic efficacy.
A herbal composition alleviates physical fatigue by activating the Nrf-2 pathway to increase HO-1 expression levels.
Increasing sarcospan expression strengthens the adhesion complex, addressing stability deficiencies that corticosteroids fail to resolve.
Differential centrifugation isolates platelet-derived exosomes from platelet-rich plasma.
Small molecule PRMT inhibitors block arginine methylation of the DUX4 protein to reduce toxic cell death.
PDE5A inhibitors block cGMP degradation to improve vasomodulation, addressing exercise-induced fatigue in muscular dystrophy patients.
Periodic anti-C5 antibody dosing targets complement activation to resolve treatment effectiveness gaps while preserving immune defense functions.
Hydrogen sulphide treatment restores fetal blood supply by stimulating angiogenesis, reducing sFlt-1 levels to address preeclampsia.
siRNA compounds degrade DUX4 mRNA to reduce aberrant protein levels, addressing inefficient epigenetic repression in facioscapulohumeral dystrophy.
Paraxanthine blends with amino acids boost muscle strength, glycogen storage, and nitric oxide signaling to address atrophy and endurance limits.
Blood cell cytokines and defined growth factors maintain muscle stem cell stemness during extensive in vitro expansion.
UCB7665 blocks FcRn recycling to lower pathogenic IgG, avoiding corticosteroid toxicity and plasma exchange burden.
Kv7 channel openers reduce muscle weakness severity and duration, addressing inadequate control from carbonic anhydrase inhibitors.
Salvia haenkei extract restores bone density and joint integrity without adverse effects from conventional anti-inflammatory drugs.
N,N-bis-2-mercaptoethyl isophthalamide regenerates ascorbate to treat chronic obstructive pulmonary disease.
Composition suppresses miRNA-106b to stabilize Pitx2, resolving progressive gene expression loss in muscular dystrophies.